LARITUM SB

bt_bb_section_bottom_section_coverage_image

Composition

Laritum SB – ceftriaxone 1g + Sulbactam 500 mg injection (intravenous route/intramuscular route of administration)
Mode of action
Ceftriaxone – 3rd generation ceplalosporin, Inhibit bacterial cell wall synthesis
Sulbactam – Beta lactamase inhibitor
Indication
Acute Bacterial Otitis Media, Prosthetic Joint Infection, Pyelonephritis, Surgical Prophylaxis, Meningitis, Skin and Soft Necrotizing Infection, Pelvic inflammatory disease, Endometritis, Gonorrhea, Intra abdominal infection, Severe Acute Bacterial Rhinosinusitis, urinary tract infection, Respiratory tract infection, Bone and joint infection
Dosage – 1 to 2gm per day in divided doses(every 12 hrs)
Contraindications – clotting disorder, low vitamin K, liver disease
Side effect – chest pain, sore throat, weakness
Adverse Drug Reaction – shortness of breath, hives, hoarseness
Drug interaction – enoxaparin, BCG vaccine, heparin

https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_04.png
https://www.larivinpharma.com/wp-content/uploads/2024/04/LARITUM-SB.jpg
https://www.larivinpharma.com/wp-content/uploads/2020/04/small_blue_triangle.png
https://www.larivinpharma.com/wp-content/uploads/2020/06/large_blue_triangle_01.png
https://www.larivinpharma.com/wp-content/uploads/2023/03/larivin-pharma-footer-icon-160x160.png
No.32, First Floor, Varadharaja Swamy Nagar, Sri Krishna Nagar, Maduravoyal, Chennai, Tamil Nadu 600095

© 2023 Larivin Pharma Private Limited. All rights reserved